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Magnetic resonance, a new method for measuring blood flow in
hemodialysis fistulae. Blood flow through arteriovenous flstulae in
patients undergoing hemodialysis needs to be within a certain range for
optimal management. Magnetic resonance (MR) velocity mapping is a
new modality that allows the noninvasive measurement of blood flow
volume. This technique was applied in 13 patients with either a
Brescia-Cimino shunt (N = 6) or a Polytetrafluoroethylene graft (Gore-
tex, N = 7). Fistula flow volume measured by MR velocity mapping
was 1386 411 mI/mm (mean SD, range 644 to 1921 mI/mm).
Interstudy reproducibility of MR velocity mapping was good (r = 0.94).
MR velocity mapping derived flow volumes showed good correlation
with values obtained with an indicator dilution technique using Indocy-
anine Green (ICG) which was performed simultaneously in eight
patients (r = 0.86). We conclude that MR velocity mapping is an
accurate noninvasive method to quantify flow volume through arterio-
venous fistulae in patients requiring hemodialysis.
Evaluation of blood flow through artenovenous fistulae is
important for clinical management of patients requiring hemo-
dialysis for renal insufficiency. Worldwide more than 60,000
patients were on hemodialysis in 1991 [1]. For optimal manage-
ment, flow volume through fistulae should be at least within the
range of 400 to 600 mI/mm [1—3]. Low flow rates preclude
effective hemodialysis while fistula flow greater than 20% of
cardiac output may induce cardiac failure [1, 2, 4]. After
surgical creation of the shunt, flow generally decreases over
time due to progressive vascular obstruction and the shunt may
ultimately become ineffective for hemodialysis [5]. Timely
intervention by radiological or surgical procedures may salvage
the shunt, while revasculanzation at a time that the fistula is
occluded is rarely successful [6]. There is a need for a method
to detect a decreased shunt flow at an early stage, for optimal
timing of intervention to prevent access failure. Conventional
imaging modalities are of limited value for measurement of
blood flow through hemodialysis fistulae. Standard contrast
angiography is the routinely used method to detect vascular
stenosis but only provides qualitative estimates of flow volume
[2]. Doppler ultrasound may provide measurements of peak
flow velocity but is of limited value for quantification of flow
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[7, 8]. In addition, Doppler ultrasound is an operator dependent
technique. Magnetic Resonance (MR) velocity mapping is a
new technique which has been shown to provide accurate
measurements of blood flow volume in large and medium sized
blood vessels. The accuracy of this method has been validated
both in vitro and in vivo [9—13].
We investigated the accuracy of MR velocity mapping for the
noninvasive measurement of blood flow through hemodialysis
fistulae. Our aims were: (1.) to evaluate the feasibility of
quantifying flow volume through hemodialysis fistulae with MR
velocity mapping, (2.) to establish the interstudy reproducibility
of the MR method, and (3.) to compare the MR based measure-
ments with an independent reference method for flow measure-
ment, which in this study is a dye dilution method.
Methods
Subjects
Thirteen patients (11 males, 2 females; mean age 53, range 27
to 74 years) were included after informed consent had been
obtained. The study was approved by our institution's Medical
Ethics committee. Six patients had a Brescia-Cimino shunt and
seven patients a Polytetrafluoroethylene (Goretex) graft inter-
position in the forearm. All arteriovenous fistulae were func-
tioning clinically well for hemodialysis treatment, according to
satisfactory biochemical laboratory parameters. In every pa-
tient, stenosis of the fistula had been excluded by means of
standard contrast angiography.
MR velocity mapping
MR velocity mapping is a relatively new technique that
allows the noninvasive evaluation of blood flow. As a distinct
advantage over other imaging modalities, exact quantification
of blood flow is possible. A technique such as (color) Doppler
ultrasound, on the other hand, provides measurements of flow
velocity only. It has proven difficult to transform these velocity
data into volumetric flow rates.
Basic to MR velocity mapping is that nuclear protons precess
(that is rotate like a top) around their axis with a frequency that
is proportional to the local magnetic field strength [14]. A
magnetic gradient is applied, resulting in faster precess (rota-
tion) of protons in stronger than in weaker parts of the field.
Subsequently, a reversal of the gradient is applied (gradient
echo), reversing this effect and thus tending to bring protons
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Fig. 1A. MR velocity mapping in
a Goretex loop using FLAG
sequence. Stationary tissue is
represented by mid grey signal
intensity. Note high signal
intensity in the afferent loop and
low signal intensity in the
efferent loop, indicating high
flow velocity (arrows). B. Flow
velocity versus time during one
heart cycle in the same patient
as A in the afferent part of the
shunt (I, solid line) and in the
venous part of the shunt (2,
dotted line). The values
represent the blood flow per
heart cycle.
III
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Fig. 2. Coronal scout view, showing the PTFE graft (straight arrows) and the imaging plane for MR velocity mapping which is perpendicular to
the graft. The curved arrows points to the fat in the distal radius and in the radial head, respectively.
back to their original precessing frequency. Protons in station-
ary tissue experience a phase change during the first gradient,
which is nullified by the second (echo) gradient. Protons in
flowing blood, because of their movement through different
field strengths, have precessed faster or slower than protons in
static tissue. These temporary frequency shifts can be used to
bring about velocity-related phase shifts which can be measured
accurately. The presence of a phase shift distinguishes protons
in flowing blood from protons in stationary tissue and the extent
of the phase shift represents their velocity.
To compensate for phase changes due to field inhomogeneity,
a pair of velocity maps is required. The first map is "velocity
compensated," containing only the phase changes due to field
inhomogeneity. The second map, in which "velocity encoding"
is applied, contains phase changes due to field inhomogeneity
and phase changes due to flow. Subtraction of the two maps
provides a velocity map which shows the phase shifts that are
due to flow only, representing the pixel by pixel flow velocities
(Fig. la). When the blood vessel runs perpendicular to the
imaging section, volume flow is calculated by multiplying vessel
cross sectional area by average flow velocity. The vessel is
outlined as the region of interest and whenever necessary the
region of interest is adjusted for movement and changes in
vessel diameter during the cardiac cycle.
As the blood flow varies over the cardiac cycle, MR data
sampling is generally triggered to the R wave of the electrocar-
diogram. Velocity maps can be obtained at 16 to 28 consecutive
time points which together span the entire cardiac cycle. The
blood flow through the vessel, in ml per cardiac cycle, is
represented by the area under the curve in the flow-time
diagram (Fig. ib).
Clinical applications of MR velocity mapping are currently
being defined. Experimental work has shown that the technique
is applicable to evaluation of the blood flow through the
pulmonary artery, the aorta, and aortic branches such as the
renal arteries [15, 16]. Further details of MR velocity mapping
are provided in references [12, 17, 18].
Imaging technique
The MR studies were performed at 1.5 Tesla (Gyroscan,
Philips Medical Systems, Best, The Netherlands). To determine
the position of the shunt, each MR examination was initiated
with obtaining a coronal plane image through the shunt (spin
echo scout, Fig. 2). The imaging plane for MR velocity mapping
was perpendicular to the long axis of the shunt and the direction
of flow. MR velocity mapping with encoding of through plane
velocity was performed using the flow adjusted gradient
(FLAG) sequence which has been described and validated
previously [9, 18, 19].
To assess the interstudy reproducibility of the technique, the
MR examination was repeated after repositioning the patient
(Fig. 3). The total imaging time was approximately 60 minutes.
Measurement 2, mI/mm
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Fig. 3. Correlation between repeated flow measurements by MR veloc-
ity mapping made after repositioning the patient. Y 0.97x — 28;
r = 0.94.
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Table 1. Flow measurements in hemodialysis shunts with
Indocyanine green and magnetic resonance velocity mapping
Patient
no.
Type of
shunt Q ICG Q MR 1 Q MR 2
1 P — 1802 1706
2 P — 1921 1816
3 P — 1367 1237
4 P — 1768 1740
5 B — 644 615
6 P 1347 1496 1646
7 B 920 954 1198
8 P 1599 1739 2041
9 B 1176 1007 1259
10 B 964 1082 1170
11 B 1328 1084 1237
12 B 1789 1850 1924
13 P 990 1299 13120 500 1000 1500 2000 2500
0.010
Abbreviations are: P, polytetrafluoroethylene graft; B, Brescia-
Cimino shunt; Q ICG, flow (Q) measured with Indocyanine green
(mi/mm); Q MR. flow (Q) measured with magnetic resonance velocity
mapping (mi/mm).
Table 2. Averages, standard deviations and range data of the results
Average
Standard
deviation Range
No. of
patients
Q ICG 1264 314 920—1789 8
QMRI 1386 411 644—1921 13
Q MR 2 1454 396 615—2041 13
Cross sectional area 1.00 0.29 0.67—1.93 13
Mean velocity 25.5 11.1 12.1—52.4 13
Peak velocity 47.6 20.6 21.5—89.3 13
Abbreviations are: Q ICG, flow (Q) measured with Indocyanine green
(mi/mm); Q MR, flow (Q) measured with magnetic resonance (mi/mm);
Cross sectional area (square centimeters); Mean velocity (cm/mm);
Peak velocity (cm/mm).
volumetric infusion pump (Harvard 22, Edenbndge, UK). in
vitro we have shown that this flow rate results in a jet infusion
stream of the infusate. Blood samples were drawn more distally
from the venous side of the shunt using a regular steel hemo-
0 200 400 600 800 1000 dialysis needle with an inner diameter of 1.2 mm and extended
Sampling time, seconds small bore tubing.Blood, for blank plasma, was sampled before the start of the
Fig. 4. Concentration of ICG in samples simultaneously obtained from infusion. Then, between 75 and 100 ml of the ICG solution (at athe shunt (dots) and from a peripheral vein (squares). These values
were obtained during a separate experiment to assess the magnitude of concentration of 0.2 mg/mI) were injected, depending on the
recirculation. The considerable effect of recirculation is indicated by the MR velocity mapping acquisition time. Blood was sampled at 1,
high ICG concentration in the peripheral samples. In the current study, 2, 4, and 6 minutes from the start of the infusion.
flow measurements by dye dilution were corrected for recirculation by The blood samples were centrifuged for six minutes at 3000 g
using the formula after Andres et al [21].
after which plasma was separated. A dye calibration curve was
prepared from each subject's blank plasma. ICG absorption
was measured on a spectrophotometer at 805 nm to determineIndocyanine Green dye dilution method
serum concentration ICG in the samples.
In seven patients, the dye dilution measurement of blood flow The blood flow through the shunt was calculated using the
through the shunt was performed simultaneously with MR formula after Jorfeldt in all patients [20]:
velocity mapping, and in one patient dye dilution was per-
formed immediately following the MR examination. The dye F1 * Ci
Indocyanine Green (ICG, Cardio-Green, Hynson, Westcott and Blood flow = (Csh — Crec) * (1 — hematocrit)
Dunning Products, Maryland, USA) was administered through
a 3 cm teflon catheter with an inner diameter of 0.5 mm placed where F1 is the rate of infusion, C. is the concentration ofICG
retrogradely in the most proximal part of the shunt. To assure solution, CSh is the dye concentration in the samples from the
thorough mixing with the blood, the indicator dye was infused venous side of the shunt, and Crec is the concentration of the
at a constant flow rate of 15 ml per minute using a precision recirculating dye.
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Fig. 5. Flow measurements with ICG versus flow derived from MR
velocity mapping, showing good correlation between the two methods.
Y = 0.78x + 239; r = 0.86.
In all patients, Crec was estimated using the formula after
Andres et a! [21].
F * C,C = *1_e(_k*t)rec CL
ln2k =
—, CL = 10.4 mI/mm/kg
T112
where CL and T112 are clearance and half-time values for ICG
obtained from healthy subjects corrected for body mass, re-
spectively. These values were used because no such data were
available for hemodialysis patients. The t is time of sampling.
Because the formula after Andres et a! for Crec was based on
values obtained in healthy subjects, the appropriateness of this
approach was investigated by obtaining the exact magnitude of
dye recirculation in five out of eight patients. For this purpose
the entire dye dilution experiment was repeated, whereby a
third catheter was inserted in the antecubital vein of the
contralateral arm for peripheral blood sampling. Samples were
taken from the shunt and from the contralateral antecubital vein
at 10, 60, 90, 120, and 240 seconds after starting the infusion and
at 30, 60, 120, 240, and 480 seconds after the infusion was
stopped (Fig. 4). Crec estimated with the formula after Andres et
a! was comparable to the Crec found in vivo.
Results
Tables 1 and 2 summarize the results in 13 patients with
arteriovenous fistulae. MR velocity mapping derived blood flow
was 1386 411 mllmin (mean SD, range 644 to 1921 mI/mm).
Average blood flow volume through Polytetrafluoroethylene
grafts (1478 434 mllmin) did not differ signfficantly from blood
flow through Brescia-Cimino shunts (1254 421 mllmin),
Student's t test. Interstudy reproducibility of the MR technique
was good, with a correlation of r = 0.94 between the two
sequential MR velocity mapping examinations (Fig. 3). The
regression equation was MR 1 = 0.97 MR 2 — 28 (m!/min).
Mean blood flow derived by dye dilution was 1264 314
mllmin (range 920 to 1789). Recirculation of the infused dye
occurred at 30 seconds after the start of infusion, increasing
during the infusion (Fig. 4). As is shown in the patient data in
Figure 4, frequent blood sampling indicated thorough mixing of
the dye. The concentrations of ICG appeared to be relatively
stable, aside from recirculation effects. The MR measurements
which were obtained simultaneously with the dye dilution
experiments were used for comparison with the ICG flow
values. These measurements are indicated in Table 1 by QMR
1. There was a good correlation of r = 0.86, between the two
methods, the regression equation being ICG = 0.78 MR + 239
(mllmin) (Fig. 5).
Discussion
Interest in the identification of decreased blood flow due to
vascular stenosis in patients with arteriovenous fistulae has
increased because of the availability and effectiveness of treat-
ment with percutaneous transluminal angioplasty [22]. It is of
clinical importance to detect decreased blood flow reflecting
vascular obstruction at an early stage to salvage the shunt by
surgical or radiological intervention. The results of our study
suggest that MR velocity mapping provides accurate and repro-
ducible measurement of flow volume through hemodialysis
fistulae. The magnitude of the blood flow through fistulae found
in the present study by means of MR velocity mapping agreed
with reported values in the literature [23].
Flow measurements by MR velocity mapping may be com-
bined with MR angiography, and the diagnostic value of such a
combined morphological and functional approach is potentially
superior to that of conventional angiography [24, 25]. Further-
more, MR imaging is noninvasive and does not require expo-
sure to ionizing radiation or administration of contrast agents.
lodinated intravenous contrast may induce hypotension, aller-
gic reactions and may also worsen renal insufficiency because
of direct nephrotoxic effects. MR velocity mapping has the
advantage over Doppler ultrasound in providing blood flow
velocity and flow volume, rather than velocity alone [8].
MR velocity mapping has been shown to provide accurate
measurements of blood flow volume in vitro [13]. In our depart-
ment we have compared MR flow measurements with a flow
phantom and have demonstrated an excellent correlation, r =
0.99 [26]. In vivo MR velocity mapping has also shown good
agreement with true flow values [10—13].
In the present study, MR velocity mapping agreed with the
results of a dye dilution technique. Dye dilution is an estab-
lished method for measuring blood flow which has been used for
determining cardiac output, the blood flow through renal arter-
ies, through the portal vein and through peripheral arteries
[27—32]. Several limitations of the dye dilution method which
preclude its use in routine clinical practice should be consid-
ered. The method is cumbersome, and inaccurate flow values
may result from inadequate mixing of the indicator dye with the
blood. Errors in measuring flow may be introduced by varia-
tions in absorption of the indicator dye, depending on concen-
tration of ICG, the solution in which ICG is dissolved, and on
room temperature [33—35]. The following assumptions underlie
quantification of blood flow through hemodialysis fistu!ae by a
dye dilution method: (1.) mixing of the indicator dye and blood
is complete [35]; (2.) the influence of recirculating dye on blood
flow measurements is negligible or is corrected for [21, 311; (3.)
the blood flow is not significantly influenced by the injection of
dye; and (4.) blood sampling does not influence blood flow. In
this study, thorough intermixture of blood and dye was accom-
plished by injecting a relatively large volume of diluted ICG
solution through a small bore catheter in a retrograde fashion,
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thus creating turbulent flow at the tip of the catheter [23]. As
found by other authors, significant recirculation of the indicator
dye occured during the infusion, resulting in inaccurately low
values of shunt flow when the uncorrected data were used
[20, 31, 36]. The correlation between MR velocity mapping and
ICG flow measurements was significantly improved when ICG
flow data were corrected for recirculation (r = 0.86, ICG flow =
0.78 MR flow + 239 (mI/mm)].
The clinical utility of functional MR measurements depends
not only on their validity but also on the reproducibility of
results. In the present study, good interstudy reproducibility
between sequential MR examination was obtained [r = 0.94,
MR(l) = 0.97 MR(2) — 28 (mI/mm)].
As a potential limiting factor of MR velocity mapping,
changes in heart rate may decrease the accuracy of flow measure-
ments. Faster MR techniques which allow real time flow mea-
surements have been recently introduced, and these are likely
to resolve this limitation [37].
In summary, we believe that MR velocity mapping has the
potential to become a useful noninvasive modality to provide
quantitative measurements of blood flow through hemodialysis
fistulae. This may be of value for early detection of a decrease
in flow to guide timely revascularization of the shunt.
Reprint requests to Louk F.I.J. Oudenhoven, M.D., Department of
Diagnostic Radiology, Leiden University Hospital, Building 1, C2-S,
Rnsburgerweg 10, 2333 AA Leiden, The Netherlands.
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